Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer

Autor: Kruger, S., Heinemann, V., Ross, C., Diehl, F., Nagel, D., Ormanns, S., Liebmann, S., Prinz-Bravin, I., Westphalen, C.B., Haas, M., Jung, A., Kirchner, T., von Bergwelt-Baildon, M., Boeck, S., Holdenrieder, S. *
Zdroj: In Annals of Oncology December 2018 29(12):2348-2355
Databáze: ScienceDirect